{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":6,"sponsored":0,"items":[{"id":"n_g23466foeuy44tjafmia","seq":1593238,"kind":"article","title":"Gilead (NASDAQ: GILD) CEO sells 15,000 shares under a preset plan","url":"https://www.themarketsdaily.com/2026/10/03/gilead-nasdaq-gild-ceo-sells-15000-shares-under-a-preset-plan.html","published":"2026-10-03T22:36:21Z","seen":"2026-10-03T22:36:21Z","lang":"en","source":{"id":"themarketsdaily.com","name":"themarketsdaily.com","domain":"themarketsdaily.com"},"via":"gdelt-gkg-english","topics":["economy","business"],"authors":["Tristan Rich"],"entities":[{"id":"Q922498","name":"Gilead","type":"org"},{"id":"Q61404233","name":"Gild","type":"org"}],"story":"st_g23466foeuy44tjafmia","category":"economy-business","category_p":0.92,"sentiment":"neutral","tone":-0.14,"political":0.08},{"id":"n_poav3sq3qewqeitzpuyq","seq":1440140,"kind":"article","title":"'Funny little arm': Gilead worker alleges leaders mocked disability, stalled career","url":"https://www.hcamag.com/us/specialization/diversity-inclusion/funny-little-arm-gilead-worker-alleges-leaders-mocked-disability-stalled-career/592157","published":"2026-10-02T22:15:00Z","seen":"2026-10-02T22:17:26Z","lang":"en","source":{"id":"hcamag.com","name":"hcamag.com","domain":"hcamag.com"},"via":"gdelt-gkg-english","topics":["economy"],"authors":["Tez Romero"],"entities":[{"id":"Q922498","name":"Gilead","type":"org"}],"story":"st_poav3sq3qewqeitzpuyq","category":"labour","category_p":0.2,"sentiment":"negative","tone":-0.74,"political":0.14},{"id":"n_cksjq54wqykkaugpnu3q","seq":514704,"kind":"article","title":"Gilead vs. Danaher: Which Healthcare Growth Story is More Convincing?","url":"https://www.insidermonkey.com/news/gilead-vs-danaher-which-healthcare-growth-story-is-more-convincing-1844046","published":"2026-09-28T20:08:19Z","seen":"2026-09-28T20:08:19Z","lang":"en","source":{"id":"insidermonkey.com","name":"insidermonkey.com","domain":"insidermonkey.com"},"via":"gdelt-gkg-english","topics":["economy","business","health"],"authors":["Noor Ul Ain Rehman"],"entities":[{"id":"Q922498","name":"Gilead","type":"org"}],"story":"st_cksjq54wqykkaugpnu3q","category":"economy-business","category_p":0.28,"sentiment":"neutral","tone":0.14,"political":0.08},{"id":"n_6lukojwfldbzslebg5kq","seq":514392,"kind":"article","title":"Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside?","url":"https://www.insidermonkey.com/news/gilead-vs-intuitive-surgical-which-healthcare-stock-offers-the-better-risk-adjusted-upside-1844047","published":"2026-09-28T20:08:19Z","seen":"2026-09-28T20:08:19Z","lang":"en","source":{"id":"insidermonkey.com","name":"insidermonkey.com","domain":"insidermonkey.com"},"via":"gdelt-gkg-english","topics":["economy","business","health"],"authors":["Noor Ul Ain Rehman"],"entities":[{"id":"Q922498","name":"Gilead","type":"org"},{"id":"Q2743863","name":"Intuitive Surgical","type":"org"}],"story":"st_6lukojwfldbzslebg5kq","category":"economy-business","category_p":0.62,"category2":"health","sentiment":"neutral","tone":0.06,"political":0.01},{"id":"n_dfi4coqcytt7y42n3fua","seq":514245,"kind":"article","title":"Gilead vs. Thermo Fisher: Which Life Sciences Stock has the Stronger Growth Outlook?","url":"https://www.insidermonkey.com/news/gilead-vs-thermo-fisher-which-life-sciences-stock-has-the-stronger-growth-outlook-1844012","published":"2026-09-28T20:08:19Z","seen":"2026-09-28T20:08:19Z","lang":"en","source":{"id":"insidermonkey.com","name":"insidermonkey.com","domain":"insidermonkey.com"},"via":"gdelt-gkg-english","topics":["economy","health","business","politics"],"authors":["Noor Ul Ain Rehman"],"entities":[{"id":"Q922498","name":"Gilead","type":"org"},{"id":"Q116723641","name":"Thermo Fisher","type":"org"}],"story":"st_dfi4coqcytt7y42n3fua","category":"economy-business","category_p":0.82,"sentiment":"neutral","tone":0.31,"political":0.01},{"id":"n_dxdxli64sedc4v3x4j2a","seq":462418,"kind":"article","title":"Mirum posts phase 3 hepatitis win for 'commercially differentiated' challenger to Gilead, Vir","url":"https://www.fiercebiotech.com/biotech/mirum-posts-phase-3-hepatitis-win-commercially-differentiated-challenger-gilead-and-vir","published":"2026-09-28T15:23:25Z","seen":"2026-09-28T15:23:25Z","lang":"en","source":{"id":"fiercebiotech.com","name":"fiercebiotech.com","domain":"fiercebiotech.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q922498","name":"Gilead","type":"org"}],"story":"st_dxdxli64sedc4v3x4j2a","category":"sport","category_p":0.44,"sentiment":"positive","tone":-0.02,"political":0.03}]}